GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pulse Biosciences Inc (STU:6L8) » Definitions » Cash Flow from Discontinued Operations

Pulse Biosciences (STU:6L8) Cash Flow from Discontinued Operations : €0.00 Mil (TTM As of Mar. 2025)


View and export this data going back to 2017. Start your Free Trial

What is Pulse Biosciences Cash Flow from Discontinued Operations?

Cash flow from discontinued operations is the cash received by a company that comes from the sale of part of business.

Pulse Biosciences's cash flow from discontinued operations for the three months ended in Mar. 2025 was €0.00 Mil. It means Pulse Biosciences received €0.00 Mil from the sale of part of business quarterly. Pulse Biosciences's cash flow from discontinued operations for the trailing twelve months (TTM) ended in Mar. 2025 was €0.00 Mil.

Pulse Biosciences Cash Flow from Discontinued Operations Historical Data

The historical data trend for Pulse Biosciences's Cash Flow from Discontinued Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pulse Biosciences Cash Flow from Discontinued Operations Chart

Pulse Biosciences Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Flow from Discontinued Operations
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Pulse Biosciences Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cash Flow from Discontinued Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Pulse Biosciences Cash Flow from Discontinued Operations Calculation

Cash received by a company that comes from the sale of part of business.

Cash Flow from Discontinued Operations for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pulse Biosciences Cash Flow from Discontinued Operations Related Terms

Thank you for viewing the detailed overview of Pulse Biosciences's Cash Flow from Discontinued Operations provided by GuruFocus.com. Please click on the following links to see related term pages.

Pulse Biosciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pulse Biosciences Inc (STU:6L8) » Definitions » Cash Flow from Discontinued Operations
Comparable Companies
KMTS AZTA BLFS STAA ATRC EMBC LMAT ANGO NNNN SMTI ISRG XPAR:EL BDX TSE:7741 XSWX:ALC RMD TSE:4543 OCSE:COLO B XPAR:DIM XSWX:STMN
Traded in Other Exchanges
PLSE:USA
Address
601 Brickell Key Drive, Suite 1080, Miami, FL, USA, 33131
Website
https://www.pulsebiosciences.com
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.

Pulse Biosciences Headlines

No Headlines